NPORT-EX 2 micro-cap.htm

Jacob Micro Cap Growth Fund
     
Schedule of Investments (+)
     
November 30, 2020 (Unaudited)
     
       
Shares
      
Value
 
    
COMMON STOCKS - 88.2%
     
    
Apparel and Accessory Stores - 2.3%
     
 
62,800
 
Tilly's, Inc. - Class A
 
$
573,364
 
      
Biological Products, (No Diagnostic Substances) - 7.0%
       
 
25,100
 
Aerie Pharmaceuticals, Inc. *
   
311,491
 
 
5,500
 
BrainStorm Cell Therapeutics, Inc. *
   
30,387
 
 
65,000
 
IMV, Inc. *^
   
252,200
 
 
6,500
 
Krystal Biotech, Inc. *
   
357,110
 
 
12,400
 
Mesoblast Ltd. - ADR *^
   
187,116
 
 
47,000
 
Precision BioSciences, Inc. *
   
586,090
 
           
1,724,394
 
      
Blank Checks - 2.9%
       
 
60,000
 
Triterras, Inc. - Class A *^
   
714,600
 
      
Bottled and Canned Soft Drinks and Carbonated Waters - 1.2%
       
 
450,000
 
Reed's, Inc. *
   
292,680
 
      
Business Services - 6.2%
       
 
136,000
 
Castlight Health, Inc. - Class B *
   
171,360
 
 
45,793
 
OptimizeRx Corp. *
   
1,209,851
 
 
120,000
 
Score Media and Gaming, Inc. - (CAD)*
   
155,232
 
           
1,536,443
 
      
Calculating and Accounting Machines (No Electronic Computers) - 1.5%
       
 
44,800
 
USA Technologies, Inc. *
   
380,800
 
      
Communications Equipment - 2.9%
       
 
103,599
 
Powerfleet, Inc. *
   
712,761
 
      
Computer & Office Equipment - 0.1%
       
 
2,000
 
IntriCon Corp. *
   
34,680
 
      
Computer Communications Equipment - 1.3%
       
 
72,879
 
Lantronix, Inc. *
   
310,465
 
      
Computer Peripheral Equipment - 5.4%
       
 
78,000
 
Identiv, Inc. *
   
537,420
 
 
58,174
 
Immersion Corp. *
   
497,969
 
 
7,200
 
Impinj, Inc. *
   
300,888
 
           
1,336,277
 
      
Computer Processing & Data Preparation - 1.8%
       
 
92,958
 
Park City Group, Inc. *
   
435,973
 
      
Direct Mail Advertising Services - 3.9%
       
 
62,415
 
SharpSpring, Inc. *
   
968,681
 
      
Eating Places - 0.6%
       
 
2,000
 
BJ's Restaurants, Inc. *
   
66,060
 
 
2,000
 
Cheesecake Factory Inc.
   
74,960
 
           
141,020
 
      
Gold and Silver Ores - 1.2%
       
 
580,000
 
Solitario Zinc Corp. *
   
284,200
 
      
Help Supply Services - 1.4%
       
 
35,000
 
Hudson Global, Inc. *
   
351,400
 
      
Industrial Organic Chemicals - 4.3%
       
 
57,006
 
Codexis, Inc. *
   
1,055,751
 
      
Medical - 1.3%
       
 
33,624
 
Celcuity, Inc. *
   
331,869
 
      
Medicinal Chemicals and Botanical Products - 0.4%
       
 
20,000
 
ChromaDex Corp. *
   
99,200
 
      
Metal Mining - 1.1%
       
 
200,000
 
Western Copper & Gold Corp. *^
   
260,000
 
      
Mining & Quarrying of Nonmetallic Mineral (No Fuels) - 0.6%
       
 
230,000
 
Azimut Exploration, Inc. *^
   
144,350
 
      
Patent Owners & Lessors - 7.0%
       
 
38,300
 
Digital Turbine, Inc. *
   
1,722,734
 
      
Pharmaceutical Preparations - 15.3%
       
 
9,000
 
Arcturus Therapeutics Holdings, Inc. *
   
825,840
 
 
230,000
 
Athersys, Inc. *
   
425,500
 
 
140,000
 
DiaMedica Therapeutics, Inc. *
   
784,000
 
 
8,800
 
Esperion Therapeutics, Inc. *
   
249,216
 
 
52,889
 
Harrow Health, Inc. *
   
304,112
 
 
18,000
 
Ideaya Biosciences, Inc. *
   
250,920
 
 
50,000
 
NeuBase Therapeutics, Inc. *
   
383,500
 
 
46,900
 
Omeros Corp. *
   
543,571
 
           
3,766,659
 
      
Prepackaged Software - 2.4%
       
 
47,010
 
Inspired Entertainment, Inc. *
   
312,617
 
 
60,000
 
Qumu Corp. *
   
291,000
 
           
603,617
 
      
Real Estate - 2.9%
       
 
160,869
 
Leju Holdings Ltd. - ADR *^
   
355,520
 
 
16,630
 
Rafael Holdings, Inc. - Class B *
   
356,215
 
           
711,735
 
      
Sausages & Other Prepared Meal Products - 0.7%
       
 
91,600
 
MamaMancini's Holdings, Inc. *
   
174,040
 
      
Security Brokers, Dealers, and Flotation Companies - 2.1%
       
 
415,000
 
Voyager Digital Ltd. *^
   
525,058
 
      
Semiconductors and Related Devices - 1.0%
       
 
6,440
 
CEVA, Inc. *
   
252,963
 
      
State Commercial Banks - 1.1%
       
 
11,015
 
First Internet Bancorp
   
281,764
 
      
Surgical and Medical Instruments and Apparatus - 8.3%
       
 
100,500
 
Alphatec Holdings, Inc. *
   
1,055,250
 
 
30,000
 
CytoSorbents Corp. *
   
251,700
 
 
74,910
 
iCAD, Inc. *
   
750,598
 
           
2,057,548
 
      
TOTAL COMMON STOCKS (Cost $12,518,571)
   
21,785,026
 
      
MONEY MARKET FUND - 11.2%
       
 
2,774,009
 
First American Government Obligations Fund - Class X, 0.05% (a)
   
2,774,009
 
      
TOTAL MONEY MARKET FUND (Cost $2,774,009)
   
2,774,009
 
      
TOTAL INVESTMENTS (Cost $15,292,580) - 99.4%
   
24,559,035
 
      
OTHER ASSETS IN EXCESS OF LIABILITIES - 0.6%
   
137,571
 
      
TOTAL NET ASSETS - 100.0%
 
$
24,696,606
 
   
   
^
U.S. Dollar-denominated foreign security.
       
   
 *
Non Income Producing.
       
   
(a)
7-day yield.
       
   
ADR
American Depositary Receipt.
       
   
(CAD)
Security denominated in Canadian dollars. Value translated into U.S. Dollars.
       
   
(+)
Schedule of Investments is classified using the U.S. Securities and Exchange Commission's Standard Industrial Classification (SIC) Code List.
       


 
Jacob Micro Cap Growth Fund Summary of Fair Value Exposure
 
 
 
 
 
 
 
Investment securities traded on a national securities exchange are valued at their market value determined by their last sales price in the principal market in which these securities are normally traded (except those traded on the NASDAQ National Market and Capital Market exchanges which are valued at the NASDAQ Official Closing Price (“NOCP”)), unless there are no transactions on the valuation date, in which case they are valued at the mean between the closing bid and ask prices. Securities traded over-the-counter are valued at the last reported sales price unless there is no reported sales price, in which case the mean between the closing bid and ask prices is used.  Foreign securities, currencies and other assets denominated in foreign currencies are translated into U.S. dollars at  the exchange rate of such currencies. Foreign equity securities are valued at the last sale price at the close of the exchange on which the security is principally traded. The Funds values foreign securities at fair value, using fair valuation procedures approved by the Board of Directors, taking into account the occurrence of events after the close of foreign markets in calculating the NAV. In such cases, use of fair valuation can reduce the investor's ability to seek profit by estimating the fund's NAV in advance of the time the NAV is calculated. The Board of Directors have retained an independent fair value pricing service to assist in valuing foreign securities held by the Funds. Debt securities with maturities of 60 days or less are valued at amortized cost, which approximates market value. Short-term securities with 60 days or less remaining to maturity are, unless conditions indicate otherwise, amortized to maturity based on their cost to the Fund if acquired within 60 days of maturity or, if already held by the Fund on the 60th day, based on the value determined on the 61st day.  If amortized cost does not approximate fair value, short-term securities are reported at fair value. Where market quotations are not readily available, are unreliable or when values have been materially affected by events occurring before the close of U.S. markets but after the close of the securities’ primary markets, securities are valued at fair value using procedures approved by the Board of Directors that are designed to determine a security’s fair value.
               
The Fund adheres to fair valuation accounting standards which provide an authoritative definition of fair value and sets out a hierarchy for measuring fair value. These standards require disclosures about the various inputs and valuation techniques used to develop the measurements of fair value and a discussion in changes in valuation techniques and related inputs during the period. These standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy is organized into three levels based upon the assumptions (referred to as “inputs”) used in pricing the asset or liability. These standards state that “observable inputs” reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from independent sources and “unobservable inputs” reflect an entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability.
Various inputs are used in determining the value of the Micro Cap Growth Fund’s investments. These inputs are summarized in the three broad levels listed below:

Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Fund  has the ability to access.
Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.  These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates and similar data.
Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Fund's own assumptions about the assumptions a market participant would use in valuing the asset or liability, and based on the best information available.
               
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
               
The following is a summary of the inputs used to value the Micro Cap Growth Fund's investments as of November 30, 2020:
   

 
 
Level 1
   
Level 2
   
Level 3
   
Total
 
Common Stocks
                       
Pharmaceutical Preparations
 
$
3,766,659
   
$
-
   
$
-
   
$
3,766,659
 
Surgical and Medical Instruments and Apparatus
   
2,057,548
     
-
     
-
     
2,057,548
 
Biological Products, (No Disgnostic Substances)
   
1,724,394
     
-
     
-
     
1,724,394
 
Patent Owners and Lessors
   
1,722,734
     
-
     
-
     
1,722,734
 
Business Services
   
1,536,443
     
-
     
-
     
1,536,443
 
Computer Peripheral Equipment
   
1,336,277
     
-
     
-
     
1,336,277
 
Industrial Organic Chemicals
   
1,055,751
     
-
     
-
     
1,055,751
 
Direct Mail Advertising Services
   
968,681
     
-
     
-
     
968,681
 
Blank Checks
   
714,600
     
-
     
-
     
714,600
 
Communications Equipment
   
712,761
     
-
     
-
     
712,761
 
Real Estate
   
711,735
     
-
     
-
     
711,735
 
Prepackaged Software
   
603,617
     
-
     
-
     
603,617
 
Apparel and Accessory Stores
   
573,364
     
-
     
-
     
573,364
 
Security Brokers, Dealers, and Flotation Companies
   
525,058
     
-
     
-
     
525,058
 
Computer Processing & Data Preparation
   
435,973
     
-
     
-
     
435,973
 
Calculating and Accounting Machines (No Electronic Computers)
   
380,800
     
-
     
-
     
380,800
 
Help Supply Services
   
351,400
     
-
     
-
     
351,400
 
Medical
   
331,869
     
-
     
-
     
331,869
 
Computer Communications Equipment
   
310,465
     
-
     
-
     
310,465
 
Bottled & Canned Soft Drinks & Carbonated Waters
   
292,680
     
-
     
-
     
292,680
 
Gold and Silver Ores
   
284,200
     
-
     
-
     
284,200
 
State Commercial Banks
   
281,764
     
-
     
-
     
281,764
 
Metal Mining
   
260,000
     
-
     
-
     
260,000
 
Semiconductors and Related Devices
   
252,963
     
-
     
-
     
252,963
 
Sausages & Other Prepared Meal Products
   
174,040
     
-
     
-
     
174,040
 
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
   
144,350
     
-
     
-
     
144,350
 
Eating Places
   
141,020
     
-
     
-
     
141,020
 
Medicinal Chemicals and Botanical Products
   
99,200
     
-
     
-
     
99,200
 
Computer & Office Equipment
   
34,680
     
-
     
-
     
34,680
 
Total Common Stocks
   
21,785,026
     
-
     
-
     
21,785,026
 
 
                               
Short Term Investment
                               
Money Market Fund
   
2,774,009
     
-
     
-
     
2,774,009
 
 
                               
Total Investments in Securities
 
$
24,559,035
   
$
-
   
$
-
   
$
24,559,035